Recipharm Lifesciences India Private Limited - Company overview

Recipharm is shown as "Amalgamated" in MCA records.

2017-02-01 Mumbai, Maharashtra Amalgamated Unlisted Active Compliant
Connect MCP

Key Metrics Public MCA facts are exact. Revenue, profit, assets, and employee figures may show as ranges until unlocked.

REVENUE
₹10–50 Lakh
▼ -19.9%
FY 2023
PROFIT / LOSS
₹1–10 Lakh
▼ -15.6%
FY 2023
EBITDA
Loss · ₹1–10 Lakh
▲ 43.5%
FY 2023
NET WORTH
₹500–1000 Cr
▲ 0.0%
FY 2023
TOTAL ASSETS
₹500–1000 Cr
▲ 0.0%
FY 2023
OPEN CHARGES
-
-
PAID-UP CAPITAL
1.00 Lakh
AUTHORISED CAPITAL
10.00 Lakh
COMPANY AGE
9 Years 8 Months
since 2017-02-01
LAST FILING WITH ROC
2024-03-31
Last AGM: 2024-09-30
ACTIVE GST
-
TOTAL MONEY RAISED
₹500–1000 Cr
SATISFIED CHARGES
-
-

Company Health Scores Scores from 0–100 based on filings, compliance signals, financials, and board history on this profile.

Health scores for Recipharm covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.

Vendor Trust Score Moderate
59/100
Overall counterparty comfort for vendors and customers.
  • Blend of compliance (23), financial health (70), director (95) and company-foundation signals.
  • Operating for 9 years.
Compliance Score High risk
23/100
Statutory filings, status and regulatory flags.
  • Company status is "Amalgamated" (not Active).
  • Last balance sheet filed for Mar 2024 - filings look overdue.
Financial Health Score Moderate
70/100
Profitability, leverage and liquidity from filed statements.
  • Profitable in FY 2023.
  • Positive net worth.
Director Risk Score Low risk
95/100
Board strength, DIN status and churn.
  • 3 directors on the board.
  • No disqualified or deactivated DINs on the current board.
Scores are derived from MCA filings, financial statements and public records on this page. Higher is safer. They are indicative, not a credit rating.
360° Intelligence Report: trust score, financial health, credit risk, growth & distress signals - auto-generated from filings. View report →

About Recipharm Company identity, industry, contact, and registration details from MCA and company records.

Recipharm is shown as "Amalgamated" in MCA records. It was registered with ROC Mumbai on 1 February 2017 as a private limited company. The registered office is at Flat No. 502, B Wing, Building No. 48, Mumbai, Maharashtra.

In its MCA filings the main business is listed as wholesale Trading.

It has three directors: Suresh Nagappa Ganachari, Emmanuel Nicolas Grand and Daniela Schalko. The longest-serving is Suresh Nagappa Ganachari, on the board since 2022; the most recent to join is Daniela Schalko, appointed in January 2025. Six former directors are on record; the most recent to leave was Rohit Kishore Sidhwani in September 2023.

₹1 lakh of its ₹10 lakh authorised capital is paid up (about 10%). Its latest balance sheet on MCA is for the year ending 31 March 2024, and the last AGM was on 30 September 2024. No charges (secured loans) are registered against it.

Pharma ••••••••
  • Location Flat No. 502, B Wing, Building No. 48,, Mumbai, Maharashtra - 400089
  • Website recipharm.com
LinkedIn YouTube
Legal NameRecipharm Lifesciences India Private Limited
CIN / LLPINU51909MH2017PTC440046
Company No.440046
ClassificationPrivate Limited Indian Non-Government Company
Incorporation Date2017-02-01
Date of AGM2024-09-30
Date of Balance Sheet2024-03-31
Listing StatusUnlisted
ROC CodeRoc Mumbai
PAN
LEI Number
Active ComplianceActive Compliant

Current Directors of Recipharm (3) Current board members from MCA filings, including designation and appointment details.

S
Suresh Nagappa Ganachari
Director | Since 2022-11-28 | DIN: 09805458
E
Emmanuel Nicolas Grand
Director | Since 2023-01-06 | DIN: 09851930
D
Daniela Schalko
Additional Director | Since 2025-01-28 | DIN: 10927117

Financial Performance of Recipharm Bands and Low / Medium / High trend shape. Exact figures unlock with your report.

Estimated bands · FY 2023
Revenue ₹10–50 Lakh ▼ -19.9%
P&L ₹1–10 Lakh ▼ -15.6%
EBITDA Loss · ₹1–10 Lakh ▲ 43.5%
Net worth ₹500–1000 Cr ▲ 0.0%

Exact figures and labelled charts require an active report plan.

Verified entity values are shown only after access is granted.

Business Activity Principal business activity and turnover mix from MCA filings.

Activity GroupDescriptionTurnover %
TradeWholesale Trading0

Financial Ratios of Recipharm Profitability, leverage, and liquidity ratios from filed statements. Exact values unlock with your report.

6 years of ratios on record

Profitability, leverage and liquidity ratios require an active report plan.

Net profit margin Debt / Equity Current ratio ROE

Unlock exact ratio values and multi-year insights.

Verified entity values are shown only after access is granted.

Shareholding Pattern of Recipharm Ownership and contribution detail from filings. Full breakdown unlocks with your report.

6 shareholder categories on record

Ownership mix and contribution history require an active report plan.

Ownership mix Category breakdown Year-wise pattern Promoter holding

Unlock full ownership and contribution details.

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Recipharm Ratings, court records, and regulatory alerts. Full risk detail unlocks with your report.

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

Rating history Court and tribunal cases Regulatory alerts Director-linked violations

Credit ratings, litigation, and regulatory alerts require an active report plan.

Verified entity values are shown only after access is granted.

MSME Payment Delays by Recipharm MSME supplier payment delays and filing history. Full amounts unlock with your report.

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

Outstanding amounts Delay periods and reasons MSME-1 filing history Vendor payment signals

MSME payment history requires an active report plan.

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Recipharm Parent, subsidiary, and related group entities. Full ownership map unlocks with your report.

1 subsidiary on record

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

Parent company Subsidiaries and ownership Associates and joint ventures Entity investments

Corporate group structure requires an active report plan.

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Recipharm Official MCA forms, returns, and filing index. Document access unlocks with your report.

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

Incorporation documents Annual returns and statements Charge filings Complete filing index

MCA filings and documents require an active report plan.

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Recipharm Common questions about this company from MCA and profile data. Some answers are limited until unlocked.
Who is the owner of Recipharm?
MCA does not publish an "owner" field. Recipharm is run by its directors, Suresh Nagappa Ganachari, Emmanuel Nicolas Grand and Daniela Schalko. The people who own the shares are listed in its annual return (form MGT-7), which can differ from the directors.
Who are the current board members and directors of Recipharm?
Recipharm has three current directors: Suresh Nagappa Ganachari (since November 2022), Emmanuel Nicolas Grand (since January 2023) and Daniela Schalko (since January 2025).
What is CIN of Recipharm?
The CIN of Recipharm is U51909MH2017PTC440046. Reading it left to right: U means it is not listed, 51909 is the industry code it registered under, MH is Maharashtra, 2017 is the year it was registered, PTC is the company type and 440046 is its registration number.
When was Recipharm incorporated?
Recipharm was incorporated on 1 February 2017 with ROC Mumbai. That makes it about 9 years old.
What is the registered address of Recipharm?
The registered office on MCA records is Flat No. 502, B Wing, Building No. 48, Mumbai, Maharashtra - 400089.
What is the current status of Recipharm?
MCA shows Recipharm as "Amalgamated". It has been merged into another company and no longer exists on its own.
What is the contact number or email for Recipharm?
You can post to its registered office at Flat No. 502, B Wing, Building No. 48, Mumbai, Maharashtra - 400089 and use its website, https://recipharm.com.
What industry or business activity is Recipharm associated with?
Its MCA filings list the main business as wholesale Trading.
What is paid-up capital and authorised share capital of Recipharm?
Paid-up capital is ₹1 lakh and authorised capital is ₹10 lakh, so about 10% of the authorised amount has been issued.
When did Recipharm last file accounts and hold an AGM?
The last AGM on record was on 30 September 2024, and the latest balance sheet is for the year ending 31 March 2024.
Where can I see charges and lenders for Recipharm?
MCA shows no charges registered against Recipharm, so no assets are pledged for a registered secured loan.
Have any directors left Recipharm?
Yes, six former directors are on record. The most recent to leave were Rohit Kishore Sidhwani (September 2023), Ketki Mahendra Save (November 2022) and Mark Quick Royston (March 2022).
What is the turnover or revenue of Recipharm?
Based on filed financial statements, the revenue of Recipharm for FY 2023 was in the ₹10–50 Lakh range. That is down 19.9% on the previous year. Exact year-wise revenue, profit and balance sheet figures are on the Financial tab.
What is the net worth of Recipharm?
For FY 2023, the net worth of Recipharm was in the ₹500–1000 Cr range.
How can I get the financial details of Recipharm?
The latest accounts on record are for FY 2023. The Financial tab has year-wise profit and loss, balance sheet and ratios, with exact figures after you sign in.
What is the official website of Recipharm?
The website on record for Recipharm is https://recipharm.com.
Which company owns recipharm.com?
recipharm.com is the website listed for Recipharm Lifesciences India Private Limited in its company records.
Recipharm - is it listed or unlisted?
Recipharm is unlisted, so its shares are not traded on a stock exchange. Its CIN starts with U for the same reason.
What is the ROC code of Recipharm?
Recipharm is registered with ROC Mumbai.
What is the company classification of Recipharm?
MCA classifies Recipharm as: Private Limited Indian Non-Government Company.
Does Recipharm have subsidiaries?
Yes, one subsidiary is on record for Recipharm.

Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.